Activation of AMPK by bitter melon triterpenoids involves CaMKKβ.
We recently showed that bitter melon-derived triterpenoids (BMTs) activate AMPK and increase GLUT4 translocation to the plasma membrane in vitro, and improve glucose disposal in insulin resistant models in vivo. Here we interrogated the mechanism by which these novel compounds activate AMPK, a leadi...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3636144?pdf=render |
id |
doaj-d67835f8a4ae4b2bb01009436d88b823 |
---|---|
record_format |
Article |
spelling |
doaj-d67835f8a4ae4b2bb01009436d88b8232020-11-25T01:15:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0184e6230910.1371/journal.pone.0062309Activation of AMPK by bitter melon triterpenoids involves CaMKKβ.Tristan J IseliNigel TurnerXiao-Yi ZengGregory J CooneyEdward W KraegenSheng YaoYang YeDavid E JamesJi-Ming YeWe recently showed that bitter melon-derived triterpenoids (BMTs) activate AMPK and increase GLUT4 translocation to the plasma membrane in vitro, and improve glucose disposal in insulin resistant models in vivo. Here we interrogated the mechanism by which these novel compounds activate AMPK, a leading anti-diabetic drug target. BMTs did not activate AMPK directly in an allosteric manner as AMP or the Abbott compound (A-769662) does, nor did they activate AMPK by inhibiting cellular respiration like many commonly used anti-diabetic medications. BMTs increased AMPK activity in both L6 myotubes and LKB1-deficient HeLa cells by 20-35%. Incubation with the CaMKKβ inhibitor, STO-609, completely attenuated this effect suggesting a key role for CaMKKβ in this activation. Incubation of L6 myotubes with the calcium chelator EGTA-AM did not alter this activation suggesting that the BMT-dependent activation was Ca(2+)-independent. We therefore propose that CaMKKβ is a key upstream kinase for BMT-induced activation of AMPK.http://europepmc.org/articles/PMC3636144?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tristan J Iseli Nigel Turner Xiao-Yi Zeng Gregory J Cooney Edward W Kraegen Sheng Yao Yang Ye David E James Ji-Ming Ye |
spellingShingle |
Tristan J Iseli Nigel Turner Xiao-Yi Zeng Gregory J Cooney Edward W Kraegen Sheng Yao Yang Ye David E James Ji-Ming Ye Activation of AMPK by bitter melon triterpenoids involves CaMKKβ. PLoS ONE |
author_facet |
Tristan J Iseli Nigel Turner Xiao-Yi Zeng Gregory J Cooney Edward W Kraegen Sheng Yao Yang Ye David E James Ji-Ming Ye |
author_sort |
Tristan J Iseli |
title |
Activation of AMPK by bitter melon triterpenoids involves CaMKKβ. |
title_short |
Activation of AMPK by bitter melon triterpenoids involves CaMKKβ. |
title_full |
Activation of AMPK by bitter melon triterpenoids involves CaMKKβ. |
title_fullStr |
Activation of AMPK by bitter melon triterpenoids involves CaMKKβ. |
title_full_unstemmed |
Activation of AMPK by bitter melon triterpenoids involves CaMKKβ. |
title_sort |
activation of ampk by bitter melon triterpenoids involves camkkβ. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2013-01-01 |
description |
We recently showed that bitter melon-derived triterpenoids (BMTs) activate AMPK and increase GLUT4 translocation to the plasma membrane in vitro, and improve glucose disposal in insulin resistant models in vivo. Here we interrogated the mechanism by which these novel compounds activate AMPK, a leading anti-diabetic drug target. BMTs did not activate AMPK directly in an allosteric manner as AMP or the Abbott compound (A-769662) does, nor did they activate AMPK by inhibiting cellular respiration like many commonly used anti-diabetic medications. BMTs increased AMPK activity in both L6 myotubes and LKB1-deficient HeLa cells by 20-35%. Incubation with the CaMKKβ inhibitor, STO-609, completely attenuated this effect suggesting a key role for CaMKKβ in this activation. Incubation of L6 myotubes with the calcium chelator EGTA-AM did not alter this activation suggesting that the BMT-dependent activation was Ca(2+)-independent. We therefore propose that CaMKKβ is a key upstream kinase for BMT-induced activation of AMPK. |
url |
http://europepmc.org/articles/PMC3636144?pdf=render |
work_keys_str_mv |
AT tristanjiseli activationofampkbybittermelontriterpenoidsinvolvescamkkb AT nigelturner activationofampkbybittermelontriterpenoidsinvolvescamkkb AT xiaoyizeng activationofampkbybittermelontriterpenoidsinvolvescamkkb AT gregoryjcooney activationofampkbybittermelontriterpenoidsinvolvescamkkb AT edwardwkraegen activationofampkbybittermelontriterpenoidsinvolvescamkkb AT shengyao activationofampkbybittermelontriterpenoidsinvolvescamkkb AT yangye activationofampkbybittermelontriterpenoidsinvolvescamkkb AT davidejames activationofampkbybittermelontriterpenoidsinvolvescamkkb AT jimingye activationofampkbybittermelontriterpenoidsinvolvescamkkb |
_version_ |
1725153218557640704 |